SROBMS 2025 Symposium

SROBMS 2025 SYMPOSIUM– PROGRAM

24.10. FRIDAY

13.00-13.15 Opening – Assoc. Prof. Dr. Daniel Grigorie, SROBMS President

13.15-14.15 Denosumab – Long-term treatment effects and denosumab discontinuation. Goal-directed therapy with denosumab – Daniel Grigorie, Carol Davila University of Medicine, National Institute of Endocrinology, Bucharest, Romania

14.15-15.15 Goal-directed treatment of osteoporosis – the importance of initial and sequential treatment choices –

Bente Langdahl, Aarhus University, Denmark

15.15-15.45 Coffee/Lunch Break

15.45-16.45 Genetics in Mineral Metabolism for Clinicians –

Michael Mannstadt, Harvard Medical School, Massachusetts General Hospital, Boston, USA

16.45-17.30 Clinical cases session: Madalina Boboc, Teodor Oprea, Laura Ilinca

17.30-18.00 Patients at imminent risk for fracture. Goal-directed therapy with teriparatide – Daniel Grigorie, Carol Davila University of Medicine, National Institute of Endocrinology, Bucharest, Romania

18.00-18.30 Romania’s experience with primary hyperparathyroidism: an East-West comparative view – Diana Coles, National Institute of Endocrinology, Bucharest, Romania

18.30-19.00 SROBMS Meeting

25.10. SATURDAY

9.00-09.45 Clinical cases session: Alina Sucaliuc, Diana Coles, Paula Ardelean

9.45-10.15 Risedronate position from the goal-treatment perspective – Daniel Grigorie, Carol Davila University of Medicine, National Institute of Endocrinology, Bucharest, Romania

10.15-10.45 Cofee break

10.45-11.30 Managing peri- and postmenopause- What’s new? – Paula Briggs, Liverpool Womens NHS Foundation Trust, UK

11.30-12.15 Osteoporosis in premenopausal women and young men – Carola Zillikens, Erasmus Medical Center Rotterdam, The Netherlands

12.15-13.00 Postmenopausal Hormone Therapy in the post-WHI times

Daniel Grigorie, Carol Davila University of Medicine, National Institute of Endocrinology, Bucharest, Romania